Medical Industry Leadership Institute Faculty
MILI faculty members bring a wealth of experience from both academia and industry—combining research prowess with practical insights to deliver valuable lessons to the next generation of healthcare leaders. They are doctors and executives, researchers and consultants, with expertise that ranges from healthcare delivery to pricing to technology and beyond.
Professor Pinar Karaca-Mandic (she/her/hers) teaches healthcare marketplace and medical technology evaluation. She is a University of Minnesota Distinguished McKnight University Professor. She is also the C. Arthur Williams Jr.
STEPHEN T. PARENTE, Ph.D., MPH, MS is a Professor in the Department of Finance and the Minnesota Insurance Industry Chair of Health Finance in Carlson School of Management at the University of Minnesota and Associate Dean of the Global Institute. From 2014-2017, he served as Associate Dean of MBA and MS programs. Dr.
Michael Finch, Ph.D., received his degree in Sociology from the University of Minnesota. Dr. Finch is known for his work on the cost, quality and financing of health care in the public and private markets.
Rahul Koranne, MD, MBA, FACP, serves as the President & Chief Executive Officer of the Minnesota Hospital Association which strives to improve the health of communities across the state by collaborating with health systems throughout Minnesota. Rahul trained in internal medicine and holds a fellowship in Geriatrics from University of Minnesota.
Dr. Carlin’s research leverages her knowledge of the health care and insurance industries, and a thorough understanding of econometrics. Her recent research focuses on the environment in which choices are made in the delivery and financing of health care services, and how this environment impacts the cost and quality of care, particularly for patients with diabetes.
Professor Ralph F. Hall is a professor of practice at the University of Minnesota Law School and teachers MILI 6421 Healthcare Law: Strategic and Business Implications. He concentrates his teaching, research and writing in the area of FDA regulation and health care. He is also a principal with Leavitt Partners, a health care policy and consulting firm.